Pharmaceutical

mRNA licensing agreements surge 800% amid GSK lawsuits

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are facing lawsuits.

Oct 20, 2024 - 04:00
mRNA licensing agreements surge 800% amid GSK lawsuits
An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are facing lawsuits.
Read the original article

Tags:

Previous Article

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Next Article

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: CRISPR-edited pig liver from eGenesis passes first test in brain-dead human, researchers say

STAT+: CRISPR-edited pig liver from eGenesis passes fir...

Jan 18, 2024

US Senate Committee calls pharma giants for another hearing on drug pricing

US Senate Committee calls pharma giants for another hea...

Nov 22, 2023

STAT+: Epic and Microsoft’s AI collaboration, Amazon and 3M, & Abbott’s CGM momentum

STAT+: Epic and Microsoft’s AI collaboration, Amazon an...

Apr 23, 2023